Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04586166 · ClinicalTrials.gov registry record · NA

Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy

A NA study of Stress Urinary Incontinence and Pelvic Floor Disorders, sponsored by Wake Forest University Health Sciences.

Recruiting
Registry status
NA
Development phase
180
Enrollment target
7
Study locations

NCT04586166 is a NA study of Stress Urinary Incontinence and Pelvic Floor Disorders that is actively recruiting participants, run by Wake Forest University Health Sciences. The registered enrollment target is 180 participants, above the 158-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (14% higher). The trial reports 7 study locations across 6 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04586166, a NA study of Stress Urinary Incontinence and Pelvic Floor Disorders, is actively recruiting participants, sponsored by Wake Forest University Health Sciences.

RECRUITING
Registry status
NA
Development phase
180 participants
Enrollment target
7
Study locations

Study Summary

SASS (Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy) will be a multicenter, prospective, randomized, single-blind non-inferiority trial.

Interventions

  • DEVICE RP Sling
  • DEVICE SIS

Study Locations (7)

Illinois

  • Northwestern Medicine - Chicago
  • University of Chicago - Chicago

Florida

  • Florida Robotic and Minimally Invasive Urogynecology - Coconut Creek

Georgia

  • Augusta University - Augusta

Massachusetts

  • Boston Urogynecology Associates - Cambridge

North Carolina

  • Wake Forest Baptist Medical Center - Winston-Salem

Other

  • Pelvic Floor Foundation of South Africa, University of Cape Town - Cape Town

Trial Details

FieldValue
Enrollment Target 180 participants
Start Date 2020-12-23
Est. Completion 2032-12
Phase NA

Sponsor

Wake Forest University Health Sciences

1,140 total trials

What the Registry Record Tells You About NCT04586166

The ClinicalTrials.gov registry entry for NCT04586166 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 180 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 158-participant average among 35 other Stress Urinary Incontinence trials with a reported enrollment target (14% higher). The listed sponsor is Wake Forest University Health Sciences, which has 1,140 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Stress Urinary Incontinence appearing as the primary indexed condition, and to 2 interventions - of which RP Sling is the first listed.

NCT04586166 reports 7 study locations spanning 6 distinct geographic areas - top geographies include Illinois, Florida, Georgia.

Frequently Asked Questions

What is clinical trial NCT04586166 about?

NCT04586166 is a clinical study titled "Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy". SASS (Single-incision Versus Retropubic Mid-Urethral Sling (Solyx) for SUI During Minimally Invasive Sacrocolpopexy) will be a multicenter, prospective, randomized, single-blind non-inferiority trial.

What is the current status of trial NCT04586166?

This trial is currently recruiting. It is a NA study. The enrollment target is 180 participants. The study started on 2020-12-23. Estimated completion is 2032-12.

What conditions does trial NCT04586166 study?

This clinical trial studies the following conditions: Stress Urinary Incontinence, Pelvic Floor Disorders.

What interventions are being tested in trial NCT04586166?

The interventions under investigation include: RP Sling (DEVICE), SIS (DEVICE).

Who is sponsoring clinical trial NCT04586166?

This trial is sponsored by Wake Forest University Health Sciences, which has 1,140 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04586166 being conducted?

This trial has 7 study locations across Florida, Georgia, Illinois, Massachusetts, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress Urinary Incontinence

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.